Explore
13D/13G Activist Filings
119,123 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Dec 24, 2025 | BALY | Bally's Corp | Standard General L.P. | 13D/A | 66.1% | 32.5M |
| Dec 24, 2025 | LXU | LSB INDUSTRIES INC | ROBOTTI ROBERT | 13D/A | 4.9% | 3.5M |
| Dec 24, 2025 | IAS | INTEGRAL AD SCIENCE HOLDING CORP. | Atlas Venture Fund VIII, L.P. | 13G/A | 0.0% | 0 |
| Dec 24, 2025 | RXRX | RECURSION PHARMACEUTICALS, INC. | Mubadala Investment Co PJSC | 13D/A | 0.0% | 0 |
| Dec 23, 2025 | MSAI | MultiSensor AI Holdings, Inc. | 325 Capital Master Fund LP | 13D/A | 13.3% | 11.6M |
| Dec 23, 2025 | BHR | Braemar Hotels & Resorts Inc. | Blackwells Capital LLC | 13D/A | 2.5% | 1.7M |
| Dec 23, 2025 | JHG | JANUS HENDERSON GROUP PLC | MASSACHUSETTS MUTUAL LIFE INSURANCE CO | 13D | 0.1% | 9K |
| Dec 23, 2025 | EVOX | Evolution Global Acquisition Corp | Linden Capital L.P. | 13G | 4.8% | 1.2M |
| Dec 23, 2025 | CAMP | CAMP4 THERAPEUTICS CORPORATION | Enavate Sciences GP, LLC | 13D/A | 6.0% | 3.1M |
| Dec 23, 2025 | IRHOU | Iron Horse Acquisition II Corp. | Linden Capital L.P. | 13G | 6.1% | 1.4M |
| Dec 23, 2025 | INDV | INDIVIOR PLC | Two Seas Capital LP | 13D/A | 5.0% | 6.2M |
| Dec 23, 2025 | YDDL | One & one Green Technologies. INC | One & One International Ltd | 13D | 54.0% | 23.8M |
| Dec 23, 2025 | LONA | Athira Pharma, Inc. | Perceptive Advisors LLC | 13D/A | 20.0% | 1.9M |
| Dec 23, 2025 | FBRX | Forte Biosciences, Inc. | Affinity Asset Advisors, LLC | 13G | 6.9% | 862K |
| Dec 23, 2025 | AIFU | AIFU INC. | Infinew Ltd | 13D/A | 5.8% | 1.2M |
| Dec 23, 2025 | AIFU | AIFU INC. | Maase Inc. | 13D/A | 7.8% | 1.6M |
| Dec 23, 2025 | AIFU | AIFU Inc. | Good Silver Limited | 13D/A | 18.6% | 3.9M |
| Dec 23, 2025 | N/A | BIMINI CAPITAL MANAGEMENT, INC. | Dwyer Robert J | 13D/A | 14.8% | 1.5M |
| Dec 23, 2025 | N/A | BIMINI CAPITAL MANAGEMENT, INC. | Haas G Hunter IV | 13D/A | 14.9% | 1.5M |
| Dec 23, 2025 | N/A | BIMINI CAPITAL MANAGEMENT, INC. | Cauley Robert E | 13D/A | 15.5% | 1.6M |
| Dec 23, 2025 | N/A | BIMINI CAPITAL MANAGEMENT, INC. | Jaumot Frank E | 13D/A | 0.3% | 36K |
| Dec 23, 2025 | AIFU | AIFU INC. | Expansion Group Ltd | 13D | 23.9% | 5.0M |
| Dec 23, 2025 | TRIB | Trinity Biotech plc | Perceptive Advisors LLC | 13D/A | 9.9% | 1.5B |
| Dec 23, 2025 | DFSC | DEFSEC Technologies Inc. | Lind Global Fund III LP | 13G | 9.9% | 197K |
| Dec 23, 2025 | N/A | Apollo Origination II (UL) Capital Trust | Apollo Direct Lending Fund II (Unlevered AIV), L.P. | 13D/A | 100.0% | 26.3M |
| Dec 23, 2025 | ATHA | Athira Pharma, Inc. | ACORN BIOVENTURES, L.P. | 13G | 2.2% | 211K |
| Dec 23, 2025 | N/A | Apollo Origination II (Levered) Capital Trust | Apollo Direct Lending Fund II (Levered AIV), L.P. | 13D/A | 100.0% | 28.0M |
| Dec 23, 2025 | FMY | First Trust Mortgage Income Fund | Sit Investment Associates, Inc. | 13D/A | 52.0% | 2.2M |
| Dec 23, 2025 | BNC | CEA Industries Inc. | YZILabs Management Ltd. | 13D/A | 4.9% | 2.2M |
| Dec 23, 2025 | N/A | Puerto Rico Residents Tax-Free Fund IV, Inc. | Ocean Capital LLC | 13D/A | 6.9% | 636K |
| Dec 23, 2025 | ZG | Zillow Group, Inc. | Richard N. Barton | 13D/A | 8.2% | 4.2M |
| Dec 23, 2025 | TENX | Tenax Therapeutics, Inc. | Perceptive Advisors LLC | 13G | 7.0% | 439K |
| Dec 23, 2025 | FGL | Founder Group Ltd | Streeterville Capital LLC | 13G | 9.9% | 2.7M |
| Dec 23, 2025 | N/A | BROOKFIELD REAL ESTATE INCOME TRUST INC. | BROOKFIELD CORPORATION | 13D/A | 32.8% | 30.5M |
| Dec 23, 2025 | ORBS | Eightco Holdings Inc. | Pantera Capital Partners LP | 13G | 6.2% | 11.6M |
| Dec 23, 2025 | COLA | Columbus Acquisition Corp/Cayman Islands | WOLVERINE ASSET MANAGEMENT LLC | 13G/A | 2.1% | 170K |
| Dec 23, 2025 | MLAC | Mountain Lake Acquisition Corp. | WOLVERINE ASSET MANAGEMENT LLC | 13G/A | 4.6% | 1.1M |
| Dec 23, 2025 | WELNF | Integrated Wellness Acquisition Corp | WOLVERINE ASSET MANAGEMENT LLC | 13G/A | 0.0% | 0 |
| Dec 23, 2025 | RDHL | RedHill Biopharma Ltd. | YA II PN, Ltd. | 13G | 9.9% | 509K |
| Dec 23, 2025 | MIMI | Mint Incorporation Limited | AL Holding Group Limited | 13G/A | 14.2% | 3.5M |
| Dec 23, 2025 | VOR | VOR BIOPHARMA INC. | ForGrowth III PA B.V. | 13D | 10.0% | 10.2M |
| Dec 23, 2025 | CCXIU | Churchill Capital Corp XI | Millennium Management LLC | 13G | 5.3% | 2.2M |
| Dec 23, 2025 | AESI | Atlas Energy Solutions Inc. | Gregory M. Shepard | 13D/A | 6.2% | 7.7M |
| Dec 23, 2025 | TRMD | TORM plc | OCM NJORD HOLDINGS S.A R.L | 13D/A | 26.1% | 26.4M |
| Dec 23, 2025 | LPCN | Lipocine Inc. | Squadron Master Fund LP | 13G | 8.0% | 445K |
| Dec 23, 2025 | ASTC | ASTROTECH Corp | Skylark Partners I, LP | 13G | 5.4% | 94K |
| Dec 23, 2025 | PIM | PUTNAM MASTER INTERMEDIATE INCOME TRUST | Sit Investment Associates, Inc. | 13D/A | 47.5% | 22.9M |
| Dec 23, 2025 | MIST | Milestone Pharmaceuticals Inc. | Propel Bio Management, LLC | 13G | 9.9% | 8.9M |
| Dec 23, 2025 | CDNL | Cardinal Infrastructure Group Inc. | Ophir Asset Management Pty Ltd | 13G | 5.3% | 700K |
| Dec 23, 2025 | PW | Power REIT | POSNER HENRY III | 13D/A | 10.0% | 340K |